Gut Barrier Protocol

A physician-designed approach to restoring the integrity of your gut lining — addressing intestinal permeability, chronic gut inflammation, and the systemic effects that follow.

At a Glance

What it targets: The integrity of the gut barrier — the single-cell-thick lining that separates your digestive tract from your bloodstream — and the chronic inflammation, dysbiosis, and systemic symptoms that follow when it’s compromised.

Who it’s for: Adults with persistent bloating, irregular bowel patterns, food sensitivities, post-antibiotic gut dysfunction, NSAID-damaged gut, or gut-driven systemic symptoms (skin, joints, fatigue).

How it works: BPC-157 and Thymosin Alpha-1 as the peptide core, NAD+ microdosing for enterocyte support, KPV layered in for active inflammation, plus microbiome rebuilding and the lifestyle layer that determines whether the gut actually heals.

What to expect: Digestive symptoms often shift first — less bloating, more predictable bowel patterns, reduced post-meal discomfort. Downstream symptoms (skin, energy, mood) often follow.

Who This Protocol Is For

India is projected to have one of the highest disease burdens of inflammatory bowel disease globally, alongside high rates of IBS, food sensitivities, and post-antibiotic gut dysfunction. Many of our clients arrive specifically researching leaky gut treatment, IBS treatment, chronic bloating cure, food sensitivity treatment, or gut healing protocols in India — and want a physician-led integrative approach that addresses gut barrier biology rather than another round of probiotics. Add post-COVID gut changes and cumulative damage from over-the-counter NSAIDs and unsupervised antibiotics, and the gut barrier picture in Indian adults is one of the most under-addressed areas in mainstream care.

This protocol was built for you if:

• Chronic bloating after meals that no dietary change has fixed
• Irregular bowel patterns — alternating constipation and loose stools, or persistent discomfort
• Food sensitivities that keep expanding — you can eat fewer things each year
• Gut symptoms that started after antibiotics, a GI infection, or heavy NSAID use
• Post-COVID gut changes that never quite returned to baseline
• Skin issues, joint pain, or chronic fatigue where your physician suspects a gut-inflammation connection

The gut is the largest immune interface in your body, produces most of your serotonin, and communicates bidirectionally with your brain, immune system, and metabolism. When the gut barrier is compromised, the effects ripple outward.

How It Works — The ALIV Approach

The intestinal lining is a single-cell-thick barrier held together by tight junctions, with mucus, immune cells, and a microbial community on top. When NSAIDs, antibiotics, chronic stress, infection, or inflammatory triggers damage this barrier, increased permeability lets unwanted antigens cross into circulation, triggering immune activation and chronic low-grade inflammation. Standard probiotic-and-fibre approaches are often insufficient when the barrier itself needs repair.

Layer 1 — The Core: BPC-157 and Thymosin Alpha-1

BPC-157 was originally isolated from human gastric juice — gut-native, stable in gastric acid. Preclinical evidence is substantial: BPC-157 stabilises tight junctions, accelerates mucosal healing, and counteracts NSAID-induced damage. A 2025 systematic review of 36 studies confirmed consistent gut-healing signals. Human controlled trials limited; not FDA-approved.

Thymosin Alpha-1 is a 28-amino-acid immune-modulating peptide. Most chronic gut dysfunction — IBS, IBD-spectrum, post-infectious changes, food sensitivities — has an immune dysregulation component. Tα1 helps re-balance immunity rather than suppressing it.

Layer 2 — NAD+ Microdosing: Enterocyte Mitochondrial Support

Enterocytes are among the most metabolically active cells in the body — they turn over every 3-5 days and depend heavily on mitochondrial function. Microdosed NAD+ supplementation supports enterocyte energy via the SIRT1-dependent pathway, preserving tight junction integrity. A supportive layer.

Layer 3 — KPV: When Inflammation Markers Are High

KPV is layered in when inflammation markers (hsCRP, ESR, calprotectin) are elevated. KPV is taken up by intestinal epithelial cells via the PepT1 transporter — upregulated in inflamed gut tissue — where it inhibits NF-κB signalling, producing targeted anti-inflammatory effects. Evidence preclinical; human trials limited.

Layer 4 — Microbiome-Aware Rebuilding

You cannot restore gut barrier integrity without addressing the ecosystem on top of it. The protocol uses targeted probiotic strains chosen based on the symptom picture, prebiotic fibres where tolerated, and dietary diversity that rebuilds microbial richness over time.

Layer 5 — Diagnostic Precision

Your ALIV physician runs a comprehensive workup — detailed history, symptom pattern, blood work (inflammatory markers, micronutrient status, food-related antibodies where indicated), stool testing where appropriate, and screening for red flags requiring gastroenterology referral: blood in stool, significant unexplained weight loss, nocturnal pain, severe persistent diarrhoea, or family history of IBD or colorectal cancer.

What to Expect

Gut-barrier restoration is multi-phase. The gut lining turns over quickly, so symptomatic improvement often begins early — but full barrier restoration and microbiome rebuilding take longer.

Individual results vary based on drivers of your gut dysfunction, duration, medication history, and adherence to the lifestyle layer. ALIV does not guarantee specific outcomes.

What’s Involved

Before starting, your ALIV medical team runs the diagnostic assessment described above. Red-flag cases route to gastroenterology workup first. Contraindications detailed in the FAQ below.

The Lifestyle Layer — Where Gut Barrier Integrity Is Made

Peptides accelerate repair. The gut barrier is rebuilt, or continues to break down, by what you do every day.

Nutritional foundation: the gut lining is metabolically expensive tissue. It requires adequate protein, glutamine (fuels enterocytes), zinc, vitamin A, and the polyphenols and fermented foods that feed a healthy microbiome. Common supplementation: Glutamine, Zinc, Omega-3, Vitamin D — tailored to assessment.

Eliminate the ongoing injury: chronic NSAID use is one of the most damaging factors for the gut lining; alcohol directly damages intestinal permeability; and India’s over-the-counter antibiotic culture quietly damages many people’s gut barrier. Avoiding unnecessary courses is critical.

Stress, sleep, and movement: the gut-brain axis is bidirectional neurobiology. Chronic stress impairs gut barrier function via cortisol; disrupted sleep degrades gut motility and microbiome composition; regular moderate movement supports motility and reduces inflammation. None are optional.

Frequently Asked Questions

Is ‘leaky gut’ actually a real medical condition?

Intestinal permeability is real and measurable — a recognised factor in IBD, food sensitivities, and several autoimmune conditions. The lay term ‘leaky gut’ describes this imprecisely, but the underlying biology is legitimate.

How do I heal a leaky gut?

Four parallel layers: remove the ongoing injury (NSAIDs, unnecessary antibiotics, alcohol, chronic stress); supply substrate (protein, glutamine, zinc, vitamin A, omega-3, polyphenols); accelerate epithelial repair via targeted intervention where indicated (BPC-157, Tα1, NAD+ microdosing, KPV when inflammation is high); and rebuild the microbial ecosystem through diversified diet and physician-selected probiotics. Generic supplement stacks rarely produce durable results.

Can IBS be cured?

Depends on cause. IBS is a heterogeneous label — covering post-infectious gut dysfunction, SIBO, food sensitivity, gut-brain dysregulation, microbiome dysbiosis. Many functional cases respond substantially to addressing the actual driver; some symptoms become manageable rather than fully resolved.

How is this different from taking probiotics?

Probiotics address microbiome composition but don’t directly repair a damaged gut barrier. Generic supplementation often produces underwhelming results. This protocol combines targeted barrier repair with microbiome work designed for your specific picture.

Do I need a gastroenterology workup first?

In many cases, yes — a feature, not a limitation. Red-flag symptoms (blood in stool, significant weight loss, nocturnal pain, severe persistent diarrhoea) require gastroenterology evaluation first. ALIV’s role is to recognise this and coordinate care, not bypass it.

What’s the evidence for these peptides in humans?

BPC-157 has substantial preclinical evidence (a 2025 systematic review of 36 studies). Thymosin Alpha-1 has the strongest human evidence base of the three — 11,000+ patients across 30+ trials, FDA-approved as Zadaxin for HBV/HCC. KPV’s mechanism is well-characterised in cell biology and animal models. Use at ALIV is investigational for gut applications with full informed consent.

Can I combine this with IBD medications I’m already on?

Possibly — but only under careful coordination with your gastroenterologist. Established IBD treatments (mesalamine, biologics, immunosuppressants) are not replaced by this protocol; the question is whether integrative support adds value alongside existing care.

Who should NOT do this protocol?

Active malignancy or undiagnosed symptoms suggesting possible malignancy; active bowel obstruction or other acute surgical conditions; untreated significant infection; pregnancy or breastfeeding; clients seeking to bypass appropriate gastroenterology workup.

Take the Next Step

If your gut hasn’t been right for years — despite diets, probiotics, and gastroenterology visits — this protocol is worth exploring.

To find out if the Gut Barrier Protocol is right for you, speak with our medical team:

• Pune (Bund Garden): +91 77199 88811
• Mumbai (Khar West): +91 98220 93069

Or book a consultation through alivtherapy.in.

Research References

1. Park JM, Lee HJ, Sikiric P, Hahm KB. BPC 157 rescued NSAID-cytotoxicity via stabilizing intestinal permeability and enhancing cytoprotection. Curr Pharm Des. 2020;26(25):2971-2981. PMID: 32445447

2. Vasireddi N, Hahamyan H, Salata MJ, et al. Emerging use of BPC-157: a systematic review. HSS J. 2025;21(4):15563316251355551. PMID: 40756949

3. Dinetz E, Lee E. Comprehensive review of the safety and efficacy of Thymosin Alpha 1 in human clinical trials. Altern Ther Health Med. 2024;30(1):6-12. PMID: 38308608

4. Li W, Zhou Y, Pang N, et al. NAD supplement alleviates intestinal barrier injury induced by ethanol via protecting epithelial mitochondrial function. Nutrients. 2022;15(1):174. PMID: 36615829

5. Dalmasso G, Charrier-Hisamuddin L, Nguyen HT, et al. PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation. Gastroenterology. 2008;134(1):166-178. PMID: 18061177

6. Kedia S, Ahuja V. Epidemiology of inflammatory bowel disease in India: the great shift East. Inflamm Intest Dis. 2017;2(2):102-115. PMID: 30018961

Disclaimer

The information on this page is for educational purposes only and is not intended as medical advice. ALIV therapies are not intended to diagnose, treat, cure, or prevent any disease, including any gastrointestinal condition. This protocol is integrative supportive care, not a replacement for specialist gastroenterology management of conditions such as inflammatory bowel disease, celiac disease, or other primary GI disorders. Outcomes vary significantly between individuals — ALIV does not guarantee specific outcomes. The peptides referenced (BPC-157, Thymosin Alpha-1, KPV) are not FDA-approved in India and are accessed via compounding pharmacies; informed consent and physician monitoring are essential. Please consult a qualified healthcare professional before starting any therapy programme.